1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,152 | 0,176 | 14:23 | |
| 0,154 | 0,174 | 14:09 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.11. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT PRESENTS LATE-BREAKING DATA FROM ONGOING PHASE 2 ENSURE STUDY AT AASLD 2025 | 1 | HKEx | ||
| 07.11. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT PUBLICATION OF PHASE 2 ENSURE STUDY RESULTS IN NATURE MEDICINE | - | HKEx | ||
| 31.10. | BRII-B (02137): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
| 28.10. | BRII-B (02137): GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | 1 | HKEx | ||
| 27.10. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 18.09. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 18.09. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| 18.09. | BRII-B (02137): 2025 INTERIM REPORT | - | HKEx | ||
| 17.09. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 27.08. | BRII-B (02137): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 | 3 | HKEx | ||
| 25.08. | Leerink Partners raises Brii Biosciences stock price target to HK$2.00 on HBV data | 2 | Investing.com | ||
| 25.08. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.08. | Brii Biosciences reports 1H results | 1 | Seeking Alpha | ||
| 21.08. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 109 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen | |
| 21.08. | BRII-B (02137): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 11.08. | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
| 04.07. | Brii Biosciences and Joincare sign licence agreement for BRII-693 | 1 | Pharmaceutical Technology | ||
| 04.07. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH JOINCARE | 2 | HKEx | ||
| 30.03. | Brii Biosciences Limited: Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification | 127 | PR Newswire | Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and... ► Artikel lesen | |
| 21.03. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results | 526 | PR Newswire | Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Data... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 148,80 | -0,27 % | Biogen stock rated Outperform by RBC Capital with $210 price target | ||
| ILLUMINA | 115,74 | +0,57 % | MyOme, Inc: Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO... ► Artikel lesen | |
| NANOREPRO | 1,525 | -0,65 % | NanoRepro: Zwei Aufsichtsräte treten zurück | Nachdem NanoRepro am Freitag das Verlangen der HWT invest Aktiengesellschaft auf Einberufung einer außerordentlichen Hauptversammlung publik gemacht hat, sind nun zwei Aufsichtsräte zurückgetreten.... ► Artikel lesen | |
| BRAIN BIOTECH | 2,590 | -1,52 % | EQS-PVR: BRAIN Biotech AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: BRAIN Biotech AG
BRAIN Biotech AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.10.2025 / 15:38 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,400 | +2,56 % | BioNxt Solutions Inc.: Über 40 % der Erwachsenen haben Schwierigkeiten beim Schlucken von Tabletten - BioNxt bekämpft weltweites Problem der Therapietreue mit schnelllöslichen "Melt-in-Your-Mouth"-Dünnfilmtherapien | VANCOUVER, BC / ACCESS Newswire /
17. Dezember 2025 / BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE:BNXT) (OTCQB:BNXTF) (FWB:BXT), ein innovatives
Biowissenschaftsunternehmen... ► Artikel lesen | |
| INFLARX | 0,911 | -4,41 % | InflaRx N.V.: InflaRx Announces International Nonproprietary Name of "Izicopan" for INF904 | JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,430 | +0,47 % | Defence Therapeutics Inc.: Defence Therapeutics Announces AGM Results and Provides Corporate Updates | Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary... ► Artikel lesen | |
| TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 1,060 | -1,85 % | Burcon NutraScience Corporation: Burcon Highlights Strong Year of Execution and Commercial Momentum in Shareholder Letter | Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based... ► Artikel lesen | |
| TME PHARMA | 0,045 | +0,68 % | TME Pharma announces receipt of agreements in principle to extend certain bond agreements | TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany, November 17, 2025, 08.00am CET - TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage... ► Artikel lesen | |
| CYTODYN | 0,256 | +3,23 % | CytoDyn Inc.: December 2025 Letter to Shareholders | VANCOUVER, Washington, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your... ► Artikel lesen | |
| IMMUNIC | 0,517 | +4,76 % | EQS-News: Immunic AG: Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December | Issuer: Immunic AG
/ Key word(s): Conference
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
26.11.2025 / 12:30 CET/CEST
The... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 1,080 | 0,00 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762 | King of Prussia, Pennsylvania--(Newsfile Corp. - November 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 2,079 | -1,66 % | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) |
Das Unternehmen BRII BIOSCIENCES LTD kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,003 (-1,95 %) liegt der Kurs bei 0,151 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.